help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Biglieri, E. G.
Right arrow Articles by Schambelan, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Biglieri, E. G.
Right arrow Articles by Schambelan, M.

Journal of Clinical Endocrinology & Metabolism, Vol 49, 87-91, Copyright © 1979 by Endocrine Society


ARTICLES

The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism

EG Biglieri and M Schambelan

Plasma 18-hydroxycorticosterone (180HB) concentration was measured in 23 patients with primary aldosteronism. After overnight recumbency, the levels were markedly elevated and were 6 times higher in patients with aldosterone-producing adenomas than in patients with hyperplasia. A value of 100 ng/dl or greater at 0800 h after overnight recumbency distinguished an adenoma from hyperplasia. There was no overlap of values, as was observed with plasma aldosterone concentration (PAC) at 0800 h and after 4 h of upright posture at 1200 h. There was a significant negative correlation between the ratio of 180HB to PAC and the potassium concentration in patients with primary aldosteronism due to hyperplasia. Potassium repletion with potassium chloride and/or spironolactone in patients with aldosterone-producing adenomas decreased the 180HB:PAC ratio by decreasing 180HB and increasing PAC. 180HB is an effective discriminator of an adenoma and may be a useful marker of the events in late aldosterone synthesis.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
J. W. Funder, R. M. Carey, C. Fardella, C. E. Gomez-Sanchez, F. Mantero, M. Stowasser, W. F. Young Jr., and V. M. Montori
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3266 - 3281.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. J. Auchus, D. W. Chandler, S. Singeetham, N. Chokshi, F. E. Nwariaku, B. L. Dolmatch, S. A. Holt, F. H. Wians Jr., S. C. Josephs, C. K. Trimmer, et al.
Measurement of 18-Hydroxycorticosterone during Adrenal Vein Sampling for Primary Aldosteronism
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2648 - 2651.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. L. Phillips, M. M. Walther, J. C. Pezzullo, W. Rayford, P. L. Choyke, A. A. Berman, W. M. Linehan, J. L. Doppman, and J. R. Gill Jr.
Predictive Value of Preoperative Tests in Discriminating Bilateral Adrenal Hyperplasia from an Aldosterone-Producing Adrenal Adenoma
J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4526 - 4533.
[Abstract] [Full Text]


Home page
NEJMHome page
A. Ganguly
Primary Aldosteronism
N. Engl. J. Med., December 17, 1998; 339(25): 1828 - 1834.
[Full Text] [PDF]


Home page
CLIN PEDIATRHome page
B. A. Dickson and R. C. Franks
Aldosterone-producing Adenoma Presenting with Hypokalemic Myopathy: Case Report and Review
Clinical Pediatrics, July 1, 1988; 27(7): 344 - 347.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1979 by The Endocrine Society